| Ian Blake Holbrook, MD | |
|
793 Eastern Byp, Richmond, KY 40475-2422 | |
| (859) 624-2229 | |
| (859) 625-9458 |
| Full Name | Ian Blake Holbrook |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 793 Eastern Byp, Richmond, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427468909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 50999 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Richmond | Richmond, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
› Verified 7 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
› Verified 7 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ian Blake Holbrook, MD 5200 Commerce Crossings Dr Fl 3, Louisville, KY 40229-2182 Ph: (502) 253-4900 | Ian Blake Holbrook, MD 793 Eastern Byp, Richmond, KY 40475-2422 Ph: (859) 624-2229 |
News Archive
Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
› Verified 7 days ago
Gina L Land, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 795 Eastern Bypass, Building 2, Suite 5, Richmond, KY 40475 Phone: 859-624-2229 Fax: 859-625-9458 | |
Mr. William Francis Sweeney, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 311 A Radio Park Dr, Richmond, KY 40475 Phone: 859-624-2010 Fax: 859-625-1229 | |
Mr. Anthony Joseph Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1054 Center Dr, Ste 5, Richmond, KY 40475 Phone: 859-623-7800 Fax: 859-624-3800 | |
William Matthew Collier, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 795 Eastern Byp, Medical Bldg.# 2 Suite 5, Richmond, KY 40475 Phone: 859-624-2229 Fax: 859-625-9458 | |
Geraldine W Spurlin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 789 Eastern Bypass, Suite 21, Richmond, KY 40475 Phone: 859-623-1404 Fax: 859-623-1405 | |
Mr. John Michael Gordon, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 311a Radio Park Dr, Richmond, KY 40475 Phone: 859-624-2010 Fax: 859-625-1229 |